BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 8206997)

  • 1. Functional human saposins expressed in Escherichia coli. Evidence for binding and activation properties of saposins C with acid beta-glucosidase.
    Qi X; Leonova T; Grabowski GA
    J Biol Chem; 1994 Jun; 269(24):16746-53. PubMed ID: 8206997
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ex vivo localization of the mouse saposin C activation region for acid beta-glucosidase.
    Qi X; Kondoh K; Yin H; Wang M; Ponce E; Sun Y; Grabowski GA
    Mol Genet Metab; 2002 Jul; 76(3):189-200. PubMed ID: 12126932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isolation, characterization, and proteolysis of human prosaposin, the precursor of saposins (sphingolipid activator proteins).
    Hiraiwa M; O'Brien JS; Kishimoto Y; Galdzicka M; Fluharty AL; Ginns EI; Martin BM
    Arch Biochem Biophys; 1993 Jul; 304(1):110-6. PubMed ID: 8323276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional organization of saposin C. Definition of the neurotrophic and acid beta-glucosidase activation regions.
    Qi X; Qin W; Sun Y; Kondoh K; Grabowski GA
    J Biol Chem; 1996 Mar; 271(12):6874-80. PubMed ID: 8636113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human acid beta-glucosidase. Use of inhibitory and activating monoclonal antibodies to investigate the enzyme's catalytic mechanism and saposin A and C binding sites.
    Fabbro D; Grabowski GA
    J Biol Chem; 1991 Aug; 266(23):15021-7. PubMed ID: 1714449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of calcium on phosphatidylserine- and saposin C-stimulated glucosylceramide beta-glucosidase activity.
    Prence EM
    Biochem J; 1995 Sep; 310 ( Pt 2)(Pt 2):571-5. PubMed ID: 7654196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Saposin C is required for normal resistance of acid beta-glucosidase to proteolytic degradation.
    Sun Y; Qi X; Grabowski GA
    J Biol Chem; 2003 Aug; 278(34):31918-23. PubMed ID: 12813057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of a mutation in a family with saposin B deficiency: a glycosylation site defect.
    Kretz KA; Carson GS; Morimoto S; Kishimoto Y; Fluharty AL; O'Brien JS
    Proc Natl Acad Sci U S A; 1990 Apr; 87(7):2541-4. PubMed ID: 2320574
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction of saposins, acidic lipids, and glucosylceramidase.
    Morimoto S; Kishimoto Y; Tomich J; Weiler S; Ohashi T; Barranger JA; Kretz KA; O'Brien JS
    J Biol Chem; 1990 Feb; 265(4):1933-7. PubMed ID: 2298731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural analysis of saposin C and B. Complete localization of disulfide bridges.
    Vaccaro AM; Salvioli R; Barca A; Tatti M; Ciaffoni F; Maras B; Siciliano R; Zappacosta F; Amoresano A; Pucci P
    J Biol Chem; 1995 Apr; 270(17):9953-60. PubMed ID: 7730378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential membrane interactions of saposins A and C: implications for the functional specificity.
    Qi X; Grabowski GA
    J Biol Chem; 2001 Jul; 276(29):27010-7. PubMed ID: 11356836
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of human saposin B sphingolipid-binding specificity by alternative splicing. A study with saposin B-derived synthetic peptides.
    Lamontagne S; Potier M
    J Biol Chem; 1994 Aug; 269(32):20528-32. PubMed ID: 8051151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of recombinant human saposin A expressed by Pichia pastoris.
    Yamada M; Inui K; Hamada D; Nakahira K; Yanagihara K; Sakai N; Nishigaki T; Ozono K; Yanagihara I
    Biochem Biophys Res Commun; 2004 May; 318(2):588-93. PubMed ID: 15120640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acid beta-glucosidase: intrinsic fluorescence and conformational changes induced by phospholipids and saposin C.
    Qi X; Grabowski GA
    Biochemistry; 1998 Aug; 37(33):11544-54. PubMed ID: 9708990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conformational and amino acid residue requirements for the saposin C neuritogenic effect.
    Qi X; Kondoh K; Krusling D; Kelso GJ; Leonova T; Grabowski GA
    Biochemistry; 1999 May; 38(19):6284-91. PubMed ID: 10320358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Saposin A: second cerebrosidase activator protein.
    Morimoto S; Martin BM; Yamamoto Y; Kretz KA; O'Brien JS; Kishimoto Y
    Proc Natl Acad Sci U S A; 1989 May; 86(9):3389-93. PubMed ID: 2717620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isolation and characterization of prosaposin from human milk.
    Kondoh K; Hineno T; Sano A; Kakimoto Y
    Biochem Biophys Res Commun; 1991 Nov; 181(1):286-92. PubMed ID: 1958198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Importance of splicing for prosaposin sorting.
    Madar-Shapiro L; Pasmanik-Chor M; Vaccaro AM; Dinur T; Dagan A; Gatt S; Horowitz M
    Biochem J; 1999 Feb; 337 ( Pt 3)(Pt 3):433-43. PubMed ID: 9895286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sphingolipid hydrolase activator proteins and their precursors.
    Sano A; Hineno T; Mizuno T; Kondoh K; Ueno S; Kakimoto Y; Inui K
    Biochem Biophys Res Commun; 1989 Dec; 165(3):1191-7. PubMed ID: 2610686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of the binding and activating sites of the sphingolipid activator protein, saposin C, with glucocerebrosidase.
    Weiler S; Kishimoto Y; O'Brien JS; Barranger JA; Tomich JM
    Protein Sci; 1995 Apr; 4(4):756-64. PubMed ID: 7613473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.